best glp-1 agonist companies The Biggest Winner of with a New Drug Breakthrough GLP-1 Receptor Agonist Market Size

At a 50% penetration rate, a 68-week course of Mounjaro would (in this ideal, nave assumption) bring the obesity rate to the lowest level its been since 1981

At present, oral GLP-1 tablets like Rybelsus are only available on the NHS for patients managing Type 2 diabetes who meet strict clinical criteria

The paper also notes substantial administrative censoring around five years, which limits the precision of later survival estimates even though the models extended to ten years

doi: 10.2337/db13-1440 28 HadjiyanniIBaggioLLPoussierPDruckerDJ

If results continue to be strong, they could be available in 24 years

And do the benefits outweigh the risk because no medication is without side effects